IP Library Granted Patent US 12,337,043
Granted Patent B2
US 12,337,043 · App. 18/400,447 · Granted Jun 24, 2025

Curable radiopaque substance

Inventor: Sebastian Pflesser (Kiel, DE)
Assignee: Merz Dental GmbH
A61K6/70A61K6/847A61K6/887C08F220/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,337,043
App. No.
18/400,447
Granted
Jun 24, 2025
Kind
B2
Abstract

A curable and radiopaque substance, a material that can be produced from same via polymerisation, a method for producing the curable substance and the cured material, and the use of the curable substance or the cured material are disclosed. The curable substance or the cured material can be used in, inter alia, orthopaedics as so-called bone cement, in particular as a tooth filling material, dental cement, dental lining material, flowable composite material (flow material) etc., as well as in diagnostic radiology. The invention also relates to the use of the curable substance generally as a construction material in an additive manufacturing process using a digital data model.

Claims (43)

1. A method for producing a curable dental material, comprising the following steps:

(i) producing or providing starting materials comprising (a) one or more polymerizable monomer(s), (b) one or more strontium, zirconium, lead, barium, bismuth or rare earth compound(s) which is/are soluble in the monomer or in the monomer mixture, (c) one or more curing initiator(s) and, (d) one or more auxiliaries,

or

producing or providing intermediates derived from the starting materials; and

(ii) mixing of the starting materials produced or provided as per step (i) or the intermediates produced or provided as per (i) to result in each case in the curable dental material,

wherein the auxiliary is an aliphatic, aromatic and/or aralkyl carboxylic acid.

2. The method of claim 1 , wherein at least one of the polymerizable monomers is selected from the group consisting of free-radically curable monomers.

3. The method of claim 2 , wherein at least one of the polymerizable monomers is selected from the group consisting of acrylic acid, acrylates, methacrylic acid and methacrylates and derivatives thereof.

4. The method of claim 3 , wherein the acrylic acid derivative and/or the methacrylic acid derivative is selected from the group consisting of acrylic esters, methacrylic esters, acrylamide and methacrylamide.

5. The method of claim 4 , wherein the acrylic acid derivative and/or methacrylic acid derivative is selected from the group consisting of methacrylic acid, butyl diglycol methacrylate, urethane dimethacrylate, isobornyl methacrylate, tetrahydrofurfuryl methacrylate, 1,4-butanediol dimethacrylate, 2-[[(butylamino)carbonyl]oxy]ethyl acrylate, bisphenol A dimethacrylate and methyl methacrylate.

6. The method of claim 1 , wherein the strontium, zirconium, lead, barium, bismuth or rare earth compound is a polymerizable strontium, zirconium, lead, barium, bismuth or rare earth compound and/or an inorganic or organic rare earth salt or a complex.

7. The method of claim 1 , wherein the strontium, zirconium, lead, barium, bismuth or rare earth compound is present in a concentration which makes the curable dental material radiopaque.

8. The method of claim 1 , wherein the curing initiator is a UV curing initiator.

9. The method of claim 1 , wherein the curing initiator consists of a 2-component redox system and contains, as auxiliary, a pulverulent component which after mixing with the liquid component results in a self-curing substance.

10. The method of claim 8 , wherein the UV initiator is selected from the group consisting of phosphine oxides, thioxanthones and camphorquinone.

11. The method of claim 8 , wherein the UV initiator is selected from the group consisting of diphenyl(2,4,6-trimethylbenzoyl) phosphine oxide (TPO), 2,4,6-trimethylbenzoylphenylphosphinate (TPO-L) and bis(2,4,6-tri-methylbenzoyl)phenylphosphine oxide (BAPO).

12. The method of claim 1 , wherein the carboxylic acid is a substituted or unsubstituted, saturated and/or unsaturated branched and/or unsaturated carboxylic acid and/or a corresponding carboxylic acid derivative functionalized on the carboxyl moiety.

13. The method of claim 12 , wherein the carboxylic acid derivative is phenylacetic acid and/or 3-phenylpropionic acid and/or trans-cinnamic acid.

14. The method of claim 1 , wherein the auxiliary is a complex former which is capable of forming a complex with an ion of the rare earth metals.

15. The method of claim 14 , wherein the complex former has at least one carbonyl function and/or at least one carboxyl function capable of forming a coordinate bond with an ion of the rare earth metals.

16. The method of claim 14 , wherein the complex former has an acetylacetone moiety or an acetylacetonate moiety.

17. The method of claim 14 , wherein the complex former has a polymerizable moiety.

18. The method of claim 17 , wherein the polymerizable moiety is represented by at least a free-radically polymerizable group.

19. The method of claim 14 , wherein the complex former is selected from the group consisting of 2-methacryloyloxyethyl acetoacetate (AAEMA), bis(2-methacryloyloxyethyl) pyromellitate, methacryloyloxyethyl phthalate, methacryloyloxyethyl maleate, methacryloyloxyethyl succinate and derivates thereof.

20. The method of claim 14 , wherein the complex former at room temperature has a vapor pressure of less than 1 mbar/20° C.

21. The method of claim 1 , wherein the curable dental material at room temperature has a vapor pressure of less than 1 mbar/20° C.

22. The method of claim 1 , wherein the curable dental material after polymerization gives a colorless or colored material transparent to electromagnetic waves in the range of visible light.

23. A method for producing a curable dental material, comprising the following steps:

(i) producing or providing starting materials comprising (a) one or more polymerizable monomer(s), (b) one or more strontium, zirconium, lead, barium, bismuth or rare earth compound(s) which is/are soluble in the monomer or in the monomer mixture, (c) one or more curing initiator(s) and, (d) one or more auxiliaries,

or

producing or providing intermediates derived from the starting materials; and

(ii) mixing of the starting materials produced or provided as per step (i) or the intermediates produced or provided as per (i) to result in each case in the curable dental material,

wherein the auxiliary is a complex former capable of forming a complex with an ion of the rare earth metals, the complex former having an acetylacetone moiety or an acetylacetonate moiety.

24. The method of claim 23 , wherein the auxiliary is an organic acid.

25. The method of claim 24 , wherein the organic acid is an organic carboxylic acid.

26. The method of claim 23 , wherein at least one of the polymerizable monomers is selected from the group consisting of free-radically curable monomers.

27. The method of claim 26 , wherein at least one of the polymerizable monomers is selected from the group consisting of acrylic acid, acrylates, methacrylic acid and methacrylates and derivatives thereof.

28. The method of claim 23 , wherein the strontium, zirconium, lead, barium, bismuth or rare earth compound is a polymerizable strontium, zirconium, lead, barium, bismuth or rare earth compound and/or an inorganic or organic rare earth salt or a complex.

29. The method of claim 23 , wherein the strontium, zirconium, lead, barium, bismuth or rare earth compound is present in a concentration which makes the curable dental material radiopaque.

30. The method of claim 29 , wherein the curing initiator is a UV curing initiator.

31. The method of claim 23 , wherein the curing initiator consists of a 2-component redox system and contains, as auxiliary, a pulverulent component which after mixing with the liquid component results in a self-curing substance.

32. The method of claim 23 , wherein the curable dental material at room temperature has a vapor pressure of less than 1 mbar/20° C.

33. The method of claim 23 , wherein the curable dental material after polymerization gives a colorless or colored material transparent to electromagnetic waves in the range of visible light.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2023
From: PFLESSER, SEBASTIAN
To: MERZ DENTAL GMBH
Reel/Frame 065985/0001 →
Priority Claims (1)
DE 10 2018 206 995.6 · May 4, 2018 · national
Continuity (3)
Division 17052437
Related Publication 20240130933A1 · Apr 25, 2024
Related Publication 20240225962A9 · Jul 11, 2024
References Cited (56)
US 3971754A · Jurecic · 1976 [cited by examiner]
US 4882392A · Smid · 1989 [cited by examiner]
US 5024232A · Smid · 1991 [cited by examiner]
US 5256334A · Smid · 1993 [cited by examiner]
US 5539017A · Rheinberger · 1996 [cited by examiner]
US 20020120033A1 · Jia · 2002 [cited by examiner]
US 20030199605A1 · Fischer · 2003 [cited by examiner]
US 20040029996A1 · Kuhn · 2004 [cited by examiner]
US 20040127597A1 · Schilke · 2004 [cited by examiner]
US 20050009946A1 · Oguri et al. · 2005 [cited by applicant]
US 20050176843A1 · Burtscher · 2005 [cited by examiner]
US 20050196726A1 · Fischer · 2005 [cited by examiner]
US 20070065780A1 · Dorsman · 2007 [cited by examiner]
US 20080085493A1 · Sun · 2008 [cited by examiner]
US 20100041789A1 · Neffgen et al. · 2010 [cited by applicant]
US 20100216096A1 · Suzuki et al. · 2010 [cited by applicant]
US 20110064776A1 · Oh · 2011 [cited by examiner]
US 20120082954A1 · Blomker et al. · 2012 [cited by applicant]
US 20140131908A1 · Sun · 2014 [cited by examiner]
US 20140138864A1 · Plaumann et al. · 2014 [cited by applicant]
US 20140239527A1 · Lee · 2014 [cited by applicant]
US 20150099821A1 · Lu · 2015 [cited by examiner]
US 20170348208A1 · MacDonald · 2017 [cited by examiner]
US 20170360534A1 · Sun · 2017 [cited by examiner]
US 20180000570A1 · Sun · 2018 [cited by examiner]
DE 2446547 · 1975 [cited by applicant]
DE 2458380 · 1975 [cited by applicant]
DE 2935810 · 1981 [cited by applicant]
DE 3421155 · 1985 [cited by applicant]
DE 4323143 · 1994 [cited by applicant]
DE 4419386 · 1995 [cited by applicant]
DE 19849388 · 2001 [cited by applicant]
DE 102006045628 · 2008 [cited by applicant]
DE 102015220373 · 2016 [cited by applicant]
EP 0143362 · 1985 [cited by applicant]
EP 0189540 · 1986 [cited by applicant]
EP 0238025 · 1987 [cited by applicant]
EP 0511868 · 1992 [cited by applicant]
EP 0717976 · 2003 [cited by applicant]
EP 1366774 · 2003 [cited by applicant]
EP 1430913 · 2004 [cited by applicant]
EP 1711433 · 2006 [cited by applicant]
EP 2153812 · 2010 [cited by applicant]
GB 1483816 · 1977 [cited by applicant]
JP 2003339850 · 2003 [cited by applicant]
JP 200576029 · 2005 [cited by applicant]
JP 2013531089 · 2013 [cited by applicant]
JP 2018500071 · 2018 [cited by applicant]
WO WO2002055028 · 2002 [cited by applicant]
WO WO2007048670 · 2007 [cited by applicant]
DE Search Report in German Appln. No. 102018206995.6, dated Feb. 25, 2019, 18 pages (with machine translation). [cited by applicant]
PCT International Search Report and Written Opinion in International Appln. No. PCT/EP2019/061330, dated Aug. 13, 2019, 22 pages (with machine translation). [cited by applicant]
PCT International Preliminary Report on Patentability in International Appln. No. PCT/EP2019/061330, dated Nov. 19, 2020, 24 pages (with English Translation). [cited by applicant]
Office Action in European Appln. No. 19723342.2, dated Apr. 25, 2022, 14 pages (with English Machine Translation). [cited by applicant]
JP Office Action in Japanese Appln. No. 2020-560891, dated Apr. 18, 2023, 10 pages (with English translation). [cited by applicant]
JP Office Action in Japanese Appln. No. 2020-560891, dated Aug. 15, 2023, 10 pages (with English Translation). [cited by applicant]